Treatment of human lactation failure

Details Treatment of human lactation failure Treatment of human lactation failure

1991-09-26

1994-01-04

Wityshyn, Michael G.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 21, 530303, 530399, A61K 3702, A61K 3736, A61K 3743, A61K 31475

Patent

active

052760146

ABSTRACT:
The invention relates to the use of hGH, hGRF, hIGF-1, hIGF-2 or analogs of these or a mixture of two or more of these, alone or in conjunction with lactational enhancers for the treatment of human lactation failure. It also relates to the use of hGH, hGRF, hIGF-1, hIGF-2 or analogs of these or a mixture of two or more of these, alone or in conjunction with lactational enhancers for the manufacturing of a medicament for the treatment of human lactation failure, also a profphlactic treatment. Preferably human growth hormone is used. The invention also relates to a method for the treatment of human lactation failure as well as compositions and methods for their manufacturing.

REFERENCES:
patent: 4783524 (1988-11-01), Larsen et al.
patent: 5061690 (1991-10-01), Kann et al.
Abribat et al. Domestic Animal Endocrinology vol. 7(1); 93-102, 1990.

Affiliated with

Also associated with

Rating

Treatment of human lactation failure does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of human lactation failure, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of human lactation failure will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-307151